Literature DB >> 33677556

Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.

Sophie Garnier1,2, Magdalena Harakalova3,4, Stefan Weiss5,6, Michal Mokry3,7,8, Vera Regitz-Zagrosek9,10, Christian Hengstenberg11,12, Thomas P Cappola13, Richard Isnard1,2,14, Eloisa Arbustini15, Stuart A Cook16,17,18, Jessica van Setten3, Jorg J A Calis3,4, Hakon Hakonarson19, Michael P Morley13, Klaus Stark20, Sanjay K Prasad17,21, Jin Li19, Declan P O'Regan22, Maurizia Grasso23, Martina Müller-Nurasyid24,25,26, Thomas Meitinger24,25,27, Jean-Philippe Empana28, Konstantin Strauch24,25,29, Melanie Waldenberger30,31, Kenneth B Marguiles13, Christine E Seidman32,33, Georgios Kararigas34, Benjamin Meder35,36, Jan Haas35, Pierre Boutouyrie28,37, Patrick Lacolley38, Xavier Jouven28,37, Jeanette Erdmann39, Stefan Blankenberg40, Thomas Wichter41, Volker Ruppert42, Luigi Tavazzi43, Olivier Dubourg44, Gérard Roizes45, Richard Dorent46, Pascal de Groote47, Laurent Fauchier48, Jean-Noël Trochu49, Jean-François Aupetit50, Zofia T Bilinska51, Marine Germain52, Uwe Völker5,6, Daiane Hemerich3, Ibticem Raji53, Delphine Bacq-Daian54,55, Carole Proust52, Paloma Remior56, Manuel Gomez-Bueno56, Kristin Lehnert6,57, Renee Maas3,4, Robert Olaso54,55, Ganapathi Varma Saripella1,58, Stephan B Felix6,57, Steven McGinn54,55, Laëtitia Duboscq-Bidot1,2, Alain van Mil3,4, Céline Besse54,55, Vincent Fontaine1,2, Hélène Blanché55,59, Flavie Ader1,60,61, Brendan Keating62, Angélique Curjol53, Anne Boland54,55, Michel Komajda1,2,63, François Cambien52, Jean-François Deleuze54,55,59, Marcus Dörr6,57, Folkert W Asselbergs3,64,65, Eric Villard1,2, David-Alexandre Trégouët52,55, Philippe Charron1,2,14,53.   

Abstract

AIMS: Our objective was to better understand the genetic bases of dilated cardiomyopathy (DCM), a leading cause of systolic heart failure. METHODS AND
RESULTS: We conducted the largest genome-wide association study performed so far in DCM, with 2719 cases and 4440 controls in the discovery population. We identified and replicated two new DCM-associated loci on chromosome 3p25.1 [lead single-nucleotide polymorphism (SNP) rs62232870, P = 8.7 × 10-11 and 7.7 × 10-4 in the discovery and replication steps, respectively] and chromosome 22q11.23 (lead SNP rs7284877, P = 3.3 × 10-8 and 1.4 × 10-3 in the discovery and replication steps, respectively), while confirming two previously identified DCM loci on chromosomes 10 and 1, BAG3 and HSPB7. A genetic risk score constructed from the number of risk alleles at these four DCM loci revealed a 3-fold increased risk of DCM for individuals with 8 risk alleles compared to individuals with 5 risk alleles (median of the referral population). In silico annotation and functional 4C-sequencing analyses on iPSC-derived cardiomyocytes identify SLC6A6 as the most likely DCM gene at the 3p25.1 locus. This gene encodes a taurine transporter whose involvement in myocardial dysfunction and DCM is supported by numerous observations in humans and animals. At the 22q11.23 locus, in silico and data mining annotations, and to a lesser extent functional analysis, strongly suggest SMARCB1 as the candidate culprit gene.
CONCLUSION: This study provides a better understanding of the genetic architecture of DCM and sheds light on novel biological pathways underlying heart failure. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  4C-sequencing; GWAS; Genetic risk score; Heart failure; Imputation;  Dilated cardiomyopathy

Mesh:

Substances:

Year:  2021        PMID: 33677556      PMCID: PMC8139853          DOI: 10.1093/eurheartj/ehab030

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  25 in total

1.  A systematic analysis of genetic dilated cardiomyopathy reveals numerous ubiquitously expressed and muscle-specific genes.

Authors:  Magdalena Harakalova; Gijs Kummeling; Arjan Sammani; Marijke Linschoten; Annette F Baas; Jasper van der Smagt; Pieter A Doevendans; J Peter van Tintelen; Dennis Dooijes; Michal Mokry; Folkert W Asselbergs
Journal:  Eur J Heart Fail       Date:  2015-03-02       Impact factor: 15.534

2.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.

Authors:  Nadine Norton; Duanxiang Li; Mark J Rieder; Jill D Siegfried; Evadnie Rampersaud; Stephan Züchner; Steve Mangos; Jorge Gonzalez-Quintana; Libin Wang; Sean McGee; Jochen Reiser; Eden Martin; Deborah A Nickerson; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

3.  A Whole-Genome Analysis Framework for Effective Identification of Pathogenic Regulatory Variants in Mendelian Disease.

Authors:  Damian Smedley; Max Schubach; Julius O B Jacobsen; Sebastian Köhler; Tomasz Zemojtel; Malte Spielmann; Marten Jäger; Harry Hochheiser; Nicole L Washington; Julie A McMurry; Melissa A Haendel; Christopher J Mungall; Suzanna E Lewis; Tudor Groza; Giorgio Valentini; Peter N Robinson
Journal:  Am J Hum Genet       Date:  2016-08-25       Impact factor: 11.025

4.  Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery.

Authors:  Krishna G Aragam; Mark Chaffin; Rebecca T Levinson; Gregory McDermott; Seung-Hoan Choi; M Benjamin Shoemaker; Mary E Haas; Lu-Chen Weng; Mark E Lindsay; J Gustav Smith; Christopher Newton-Cheh; Dan M Roden; Barry London; Quinn S Wells; Patrick T Ellinor; Sekar Kathiresan; Steven A Lubitz
Journal:  Circulation       Date:  2018-11-11       Impact factor: 29.690

5.  Annotation of functional variation in personal genomes using RegulomeDB.

Authors:  Alan P Boyle; Eurie L Hong; Manoj Hariharan; Yong Cheng; Marc A Schaub; Maya Kasowski; Konrad J Karczewski; Julie Park; Benjamin C Hitz; Shuai Weng; J Michael Cherry; Michael Snyder
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

6.  Long-range epigenetic regulation is conferred by genetic variation located at thousands of independent loci.

Authors:  Mathieu Lemire; Syed H E Zaidi; Maria Ban; Bing Ge; Dylan Aïssi; Marine Germain; Irfahan Kassam; Mike Wang; Brent W Zanke; France Gagnon; Pierre-Emmanuel Morange; David-Alexandre Trégouët; Philip S Wells; Stephen Sawcer; Steven Gallinger; Tomi Pastinen; Thomas J Hudson
Journal:  Nat Commun       Date:  2015-02-26       Impact factor: 14.919

7.  A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African Americans.

Authors:  Huichun Xu; Gerald W Dorn; Amol Shetty; Ankita Parihar; Tushar Dave; Shawn W Robinson; Stephen S Gottlieb; Mark P Donahue; Gordon F Tomaselli; William E Kraus; Braxton D Mitchell; Stephen B Liggett
Journal:  J Pers Med       Date:  2018-02-26

8.  LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis.

Authors:  Jie Zheng; A Mesut Erzurumluoglu; Benjamin L Elsworth; John P Kemp; Laurence Howe; Philip C Haycock; Gibran Hemani; Katherine Tansey; Charles Laurin; Beate St Pourcain; Nicole M Warrington; Hilary K Finucane; Alkes L Price; Brendan K Bulik-Sullivan; Verneri Anttila; Lavinia Paternoster; Tom R Gaunt; David M Evans; Benjamin M Neale
Journal:  Bioinformatics       Date:  2016-09-22       Impact factor: 6.937

9.  Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy.

Authors:  James P Pirruccello; Alexander Bick; Minxian Wang; Mark Chaffin; Samuel Friedman; Jie Yao; Xiuqing Guo; Bharath Ambale Venkatesh; Kent D Taylor; Wendy S Post; Stephen Rich; Joao A C Lima; Jerome I Rotter; Anthony Philippakis; Steven A Lubitz; Patrick T Ellinor; Amit V Khera; Sekar Kathiresan; Krishna G Aragam
Journal:  Nat Commun       Date:  2020-05-07       Impact factor: 17.694

10.  Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.

Authors:  Matthias Heinig; Michiel E Adriaens; Sebastian Schafer; Hanneke W M van Deutekom; Elisabeth M Lodder; James S Ware; Valentin Schneider; Leanne E Felkin; Esther E Creemers; Benjamin Meder; Hugo A Katus; Frank Rühle; Monika Stoll; François Cambien; Eric Villard; Philippe Charron; Andras Varro; Nanette H Bishopric; Alfred L George; Cristobal Dos Remedios; Aida Moreno-Moral; Francesco Pesce; Anja Bauerfeind; Franz Rüschendorf; Carola Rintisch; Enrico Petretto; Paul J Barton; Stuart A Cook; Yigal M Pinto; Connie R Bezzina; Norbert Hubner
Journal:  Genome Biol       Date:  2017-09-14       Impact factor: 13.583

View more
  7 in total

1.  Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation.

Authors:  Yunju Yang; Traci M Bartz; Michael R Brown; Xiuqing Guo; Nuno R Zilhão; Stella Trompet; Stefan Weiss; Jie Yao; Jennifer A Brody; Christopher R Defilippi; Ron C Hoogeveen; Henry J Lin; Vilmundur Gudnason; Christie M Ballantyne; Marcus Dörr; J Wouter Jukema; Astrid Petersmann; Bruce M Psaty; Jerome I Rotter; Eric Boerwinkle; Myriam Fornage; Goo Jun; Bing Yu
Journal:  Circ Genom Precis Med       Date:  2021-11-04

2.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

3.  Effect of taurine administration on symptoms, severity, or clinical outcome of dilated cardiomyopathy and heart failure in humans: a systematic review.

Authors:  Kathryn A McGurk; Melpomeni Kasapi; James S Ware
Journal:  Wellcome Open Res       Date:  2022-07-07

4.  The year in cardiovascular medicine 2021: heart failure and cardiomyopathies.

Authors:  Johann Bauersachs; Rudolf A de Boer; JoAnn Lindenfeld; Biykem Bozkurt
Journal:  Eur Heart J       Date:  2022-02-03       Impact factor: 35.855

5.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

Review 6.  Insights on Human Small Heat Shock Proteins and Their Alterations in Diseases.

Authors:  B Tedesco; R Cristofani; V Ferrari; M Cozzi; P Rusmini; E Casarotto; M Chierichetti; F Mina; M Galbiati; M Piccolella; V Crippa; A Poletti
Journal:  Front Mol Biosci       Date:  2022-02-25

7.  Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).

Authors:  Rudolf A de Boer; Stephane Heymans; Johannes Backs; Lucie Carrier; Andrew J S Coats; Stefanie Dimmeler; Thomas Eschenhagen; Gerasimos Filippatos; Lior Gepstein; Jean-Sebastien Hulot; Ralph Knöll; Christian Kupatt; Wolfgang A Linke; Christine E Seidman; C Gabriele Tocchetti; Jolanda van der Velden; Roddy Walsh; Petar M Seferovic; Thomas Thum
Journal:  Eur J Heart Fail       Date:  2022-01-14       Impact factor: 17.349

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.